Introduction
============

Among the many mechanisms driving genome evolution and phenotypic change, gene duplication is arguably one of the most influential processes, as it provides raw material from which genes with diverse functions can evolve ([@msx237-B46]; [@msx237-B22]). Duplication events not only shape genomes at large evolutionary time scales but also have been shown to produce rapid adaptive changes at the population level ([@msx237-B49]; [@msx237-B59]; [@msx237-B5]). However, in most cases, one of the duplicated copies becomes pseudogenized due to functional redundancy ([@msx237-B42]). Except in the rare cases where an increased dosage of the ancestral gene product is advantageous, the duplicates need to diverge rapidly in protein function and/or expression before one copy is lost through pseudogenization ([@msx237-B46]; [@msx237-B42]; [@msx237-B22]; [@msx237-B5]).

The process of expression divergence between paralogs, in particular, has received much attention from previous studies ([@msx237-B14]; [@msx237-B51]; [@msx237-B32]; [@msx237-B3]; [@msx237-B48]). To explain the maintenance of duplicated copies, two main types of expression divergence have been proposed. First, each paralog can rapidly adopt distinct tissue, spatial or temporal specificities, thus making the two copies nonredundant ([@msx237-B22]). This process can occur through the acquisition of new expression (neofunctionalization) or through the partitioning of the original expression domains between the two copies (subfunctionalization) ([@msx237-B46]; [@msx237-B14]; [@msx237-B23]; [@msx237-B22]). A classical model of subfunctionalization is the duplication--degeneration--complementation model, which postulates that *cis-*regulatory elements duplicated along with their coding sequences undergo complementary degeneration by neutral drift, eventually producing complementary expression patterns ([@msx237-B14]). As this model requires the complete duplication of regulatory regions, it may be common in duplicate pairs resulting from whole-genome duplications or large-segmental duplications ([@msx237-B7]; [@msx237-B29]; [@msx237-B35]; [@msx237-B33]).

Alternatively, changes in the expression levels of paralogs can lead to their retention ([@msx237-B14]; [@msx237-B22]; [@msx237-B52]; [@msx237-B19]; [@msx237-B37]; [@msx237-B64]). According to the dosage sharing model (or quantitative subfunctionalization), the expression of the two copies in a given tissue is reduced to match the level originally produced by the unduplicated ortholog, thus making the contribution of both copies indispensable ([@msx237-B14]; [@msx237-B37]). As a corollary, paralogs can maintain the same expression domains for prolonged periods of time, although their relative expression levels may vary in different lineages. Eventually, one copy can lose expression in some tissues culminating in a subfunctionalization event ([@msx237-B19]; [@msx237-B37]; [@msx237-B64]). Interestingly, recent genome-wide studies in mammals and *Drosophila yakuba* populations have provided evidence indicating that dosage sharing may be a prevalent mechanism for the maintenance of tandem gene duplicates, which are more likely to be coregulated by their shared *cis-*regulatory environment ([@msx237-B37]; [@msx237-B54]).

Although many of the theoretical studies and experimental work examining the expression divergence between gene duplicates invoke different *cis-*regulatory mechanisms, few studies have directly investigated *cis-*regulatory evolution in duplicated loci ([@msx237-B25]; [@msx237-B29]; [@msx237-B35]; [@msx237-B38]). Thus, there is a conspicuous lack of empirical data relating changes in *cis-*regulatory landscape to paralog expression divergence.

*Drosophila melanogaster* and its related species provide a solid phylogenetic framework to study *cis-*regulatory evolution and have been explored to unveil the nature of molecular changes underlying differences in gene expression between species ([@msx237-B41]; [@msx237-B30]; [@msx237-B16]; [@msx237-B2]; [@msx237-B1]; [@msx237-B4]; [@msx237-B67]). Here, we used this system to investigate the expression divergence of a pair of tandem duplicates and its underlying *cis*-regulatory bases*.* For this purpose, we chose the *CG9336* and *CG9338* paralogs, which arose from a single duplication event that occurred between 60 and 40 Ma and are found in all sequenced *Drosophila* species ([@msx237-B62]). Although the biological function of these genes has not yet been described, these duplicates belong to the insect Ly6 gene family, whose small protein products function as membrane ligands capable of binding to a wide range of targets in different biological contexts ([@msx237-B18]; [@msx237-B24]; [@msx237-B44]; [@msx237-B66]; [@msx237-B34]; [@msx237-B11]). Previous comparison of the embryonic expression patterns of *CG9336* and *CG9338* in *D. melanogaster* showed that these genes retain some of the tissue specificities of the unduplicated ortholog found in the tephritid *Ceratitis capitata* ([@msx237-B62]). However, they have also diverged from each other and the unduplicated ortholog, both by partitioning of the ancestral expression pattern and by acquisition of novel expression domains ([@msx237-B62]).

In this study, we have first characterized the tissue specificities of *CG9336* and *CG9338* expression in three additional *Drosophila* species to understand how and when the expression divergence arose. We then compared the enhancer activities of the entire locus in all four species to elucidate the *cis*-regulatory mechanisms underlying the expression evolution of the duplicates. We found that expression divergence, encompassing both sub- and neo-functionalization occurred both close to the time of duplication and more recently in a lineage-specific manner. Comparative analysis of the locus-wide c*is*-regulatory landscapes uncovered the presence of *cis-*regulatory modules (CRMs) associated with both the subfunctionalization events and the emergence of new expression domains underlying neofunctionalization. Surprisingly, some conserved tissue expression also appears to be driven by highly variable *cis*-regulatory architecture, highlighting the dynamic *cis*-regulatory basis of paralog expression evolution.

Results
=======

To gain new insights into the mechanisms underlying paralog evolution, we chose to analyze in detail the process of expression divergence undergone by two *Drosophila* duplicates, *CG9336* and *CG9338* ([@msx237-B62]). A survey of multiple *Drosophila* species and two tephritid genomes indicates that these tandem duplicates arose in a common ancestor of drosophilids ([fig. 1*A*](#msx237-F1){ref-type="fig"}). Their divergence has therefore accompanied the radiation of this group for more than 40 My. Comparison of the genomic annotations reveals that the two paralogs and their intron--exon structures have been preserved across *Drosophila* species ([fig. 1*A* and *B*](#msx237-F1){ref-type="fig"}). In contrast, the adjacent and intervening noncoding regions have undergone alterations in different lineages, namely the insertion of different coding sequences in neighboring positions. Moreover, *CG9336* and *CG9338* have experienced further rounds of duplication in some lineages, producing additional species-specific paralogs ([fig. 1*A*](#msx237-F1){ref-type="fig"}).

![Evolution of the *CG9336*--*CG9338* genomic region after gene duplication. (*A*) Organization of the *CG9336*--*CG9338* genomic region in different drosophilid and tephritid species. The phylogeny of the 14 species analyzed is on the left. Ortholog coding sequences are labeled using the same color code. The two paralogs originated from a duplication event in a common ancestor of the drosophilids. Several genomic insertions containing coding sequences for unrelated genes are found in some lineages. In addition, the region experienced additional duplications involving one or more coding units in *D. erecta* and *D. willistoni*. In *D. melanogaster*, the *CR9337* coding region has been pseudogenized (asterisk). (*B*) Sequence alignment of protein products encoded by *CG9336* (blue), *CG9338* (red) and the unduplicated ortholog (black) in different drosophilid and tephritid species. Residues conserved in all three proteins are shown in red, whereas conserved amino acids specific to each paralog appear in blue. The exon structure and the different protein functional domains are also indicated. Highly conserved cysteine residues diagnostic of the Ly6 protein family are labeled with red circles.](msx237f1){#msx237-F1}

The Protein Products of *CG9336* and *CG9338* Exhibit Both Conserved and Divergent Features
-------------------------------------------------------------------------------------------

The coding sequences of the two paralogs have diverged during drosophilid evolution ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), but their respective protein products display all the typical features of Ly6 family members: an N-terminal signal peptide, a three-fingers Ly6 domain with 10 conserved cysteines in stereotypical positions, and a short hydrophobic C-terminus that is cleaved for glycosylphosphatidylinositol-anchor addition during protein maturation ([fig. 1*B*](#msx237-F1){ref-type="fig"}) ([@msx237-B24]; [@msx237-B44]). We have previously shown that the paralog coding sequences have been maintained under purifying selection, indicating that the two proteins could perform distinct functions ([@msx237-B62]). To explore this possibility, we generated versions of both proteins with a fluorescent tag (mCherry) under the control of inducible promoters and compared their subcellular localizations in different tissues ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}*C--E* and *G--I*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). We observed that the two gene products localize to the cell membrane, and their overall distributions are indistinguishable ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}*C--E* and *G--I*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Thus, despite some degree of divergence at the levels of primary sequence and tissue-specific expression (see below), both proteins act in the same subcellular compartments. It is therefore possible that the two paralogs play redundant roles in tissues where they are coexpressed, although we cannot rule out that they may have acquired distinct targets.

Expression Divergence of *CG9336* and *CG9338* in *D. melanogaster* and *C. capitata*
-------------------------------------------------------------------------------------

Previous analyses showed that *CG9336* and *CG9338* are expressed in *D. melanogaster* embryos in both common and nonoverlapping domains, indicating that their tissue specificities have diverged after duplication ([@msx237-B62]). To gain a more complete picture of this divergence, we conducted an exhaustive analysis of their expression patterns not only during embryogenesis but also in third instar larvae. We examined their expression using both paralog-specific riboprobes and yellow fluorescent protein (YFP) reporters for each gene, which faithfully reproduce the endogenous patterns and allow a higher cellular resolution and a more accurate assessment of expression levels ([@msx237-B40]; [@msx237-B62]).

Both duplicates are expressed in glial tissues throughout development, but their relative levels vary in different glial subtypes, adopting in some cases complementary patterns ([fig. 2](#msx237-F2){ref-type="fig"}). For instance, although *CG9336* levels are higher, both paralogs are expressed in the embryonic glia associated with the peripheral nervous system (hereafter referred to as "axonal glia"; [fig. 2*A, B, G*, and *H*](#msx237-F2){ref-type="fig"}) in the wrapping glia of the larval eye disc (hereafter referred to as "eye wrapping glia"; [fig. 2*M* and *S*](#msx237-F2){ref-type="fig"}) and in the midline glia ([fig. 2*A, B, G, H*, *N*, and *T*](#msx237-F2){ref-type="fig"}). In the surface glia of the embryonic central nervous system (CNS), however, only *CG9336* is expressed ([fig. 2*A* and *B*](#msx237-F2){ref-type="fig"}). In turn, *CG9338* levels are higher in the larval CNS surface glia, and only this paralog is expressed in the eye carpet glia and the larval axonal glia ([fig. 2*S--V*](#msx237-F2){ref-type="fig"}).

![Embryonic and larval expression patterns of *CG9336* and *CG9338* in *D. melanogaster*. (*A--F*) Expression of *CG9336* mRNA (*A, C, E, F*) and the YFP-tagged protein product (*B, D*) in the embryo. In situ hybridization showing the *CG9336* mRNA distribution in stage 16 (*A, F*), late stage 17 (*E*), and stage 15 embryos (*C*). The transcript is strongly expressed in the peripheral axon glia (red arrow, *A*), CNS surface glia (white arrow, *A*), and the midline glia (red arrowhead, *A*), the Bolwig's organ (white arrow, *E*), hindgut boundary cells (red arrow, *E*), and the heart (white arrow, *F*). (*B, D*) Projections of confocal stacks showing the stage 16 embryos expressing CG9336-YFP and stained with a GFP antibody (green in *B*, b/w in *D*). (*B*) Expression is detected in glial cells (axonal glia, red arrow; CNS surface glia, white arrow) coexpressing the glial marker Repo (magenta) and in the midline glia (red arrowhead). (*C*) No expression is detected in the hemocytes. Asterisks, midline glia. (*D*) Expression is also seen in a ring of cells around the anal plate in the most posterior part of the embryo. (*G--L*) Expression of *CG9338* mRNA (*G, I, K, L*) and YFP-tagged protein product (*H, J*) in the embryo. In situ hybridization showing the *CG9338* mRNA distribution in stage 16 (*G, L*), late stage 17 (*K*), and stage 15 embryos (*I*). The transcript signal is detected in the peripheral glia (red arrow, *G*), the midline glia (red arrowhead, *G*), the Bolwig's organ (white arrow, *K*), the heart (white arrow, *L*), and the hemocytes (black arrowheads, *I*). The signal was not detected in the hindgut boundary cells (*K*). (*H, J*) Projections of confocal stacks showing the stage 16 embryos expressing CG9338-YFP and stained with a GFP antibody (green in *H*, b/w in *J*). Expression is seen in axonal glial cells (red arrow, *H*) coexpressing Repo (magenta in *H*) and, at lower levels, in the midline glia (red arrowhead, *H*) and the anal plate (*J*). (*M--R*) Expression of the CG9336 YFP-tagged protein product revealed with a GFP antibody (green in *M, P, Q*, b/w in *N, O, R*) in third instar larvae. The CG9336-YFP-tagged protein distribution in the eye disc (*M*) reveals that the expression is in wrapping glial cells (white arrowhead). (*N*) In the larval CNS, high levels of expression in the midline glia (red arrowhead) and in the CAPA neurons (white arrowhead) are detected. Asterisk indicates the tracheal branches. We also detect expression in the large flat cells of the CNS surface glia (*O*, white arrow), but the signal is absent in the axonal glia (*P*, labeled in magenta with the Repo marker). The YFP-tagged protein is also detected in the nephrocytic garland cells (white arrow in *Q*; magenta shows TOPRO nuclear staining) and in the hindgut boundary cells (red arrow, *R*). (*S--X*) Expression of the CG9338 YFP-tagged protein product revealed with a GFP antibody (green in *S, V, W*, b/w in *T, U, X*) in third instar larvae. (*S*) In the larval eye disc, the CG9338-YFP protein trap is expressed in the wrapping glia (white arrowhead) and in the carpet cells (white arrow). In the larval CNS, a high level of expression is detected in the axonal glia (red arrow in *T* and *V*; Repo marker is in magenta) and the surface glia (*U*, white arrow). CG9338-YFP is detected neither in the nephrocytic garland cells (*W*, magenta shows TOPRO nuclear staining) nor in the hindgut (*X*).](msx237f2){#msx237-F2}

We observe a similar trend in other tissues. The embryonic Bolwig's organ ([fig. 2*E* and *K*](#msx237-F2){ref-type="fig"}), the heart ([fig. 2*F* and *L*](#msx237-F2){ref-type="fig"}), and a ring of epidermal cells surrounding the embryonic anal plate ([fig. 2*D* and *J*](#msx237-F2){ref-type="fig"}) express both genes, although *CG9338* is seen at much lower levels in the latter two tissues. Meanwhile, only *CG9336* is detected in two rows of hindgut epithelial cells known as boundary cells ([fig. 2*E* and *R*](#msx237-F2){ref-type="fig"}) ([@msx237-B28]), in the nephrocytic garland cells ([fig. 2*Q*](#msx237-F2){ref-type="fig"}), and in the CAPA-producing neurons of the CNS ([fig. 2*N*](#msx237-F2){ref-type="fig"}) ([@msx237-B57]). In turn, *CG9338* is the only paralog expressed in the embryonic hemocytes ([fig. 2*I*](#msx237-F2){ref-type="fig"}).

Comparing the expression patterns of *CG9336* and *CG9338* with that of their unduplicated ortholog (*a-36/38*) in *C. capitata* ([fig. 3*A--H*](#msx237-F3){ref-type="fig"}), we could assess for each expression domain whether it was inherited by both *Drosophila* paralogs (conservation), by only one of them (subfunctionalization) or whether it constituted a novel acquisition (neofunctionalization) ([fig. 3*I*](#msx237-F3){ref-type="fig"}). We infer that both paralogs inherited expression in the Bolwig's organ, the embryonic axonal glia, and the eye disc glia ([fig. 3*B, D, G*, and *I*](#msx237-F3){ref-type="fig"}). In contrast, the expression in the hindgut and the embryonic CNS surface glia appears to have been retained only by *CG9336* ([fig. 3*B, E*, and *I*](#msx237-F3){ref-type="fig"}). Finally, the expression in the heart, the hemocytes, and the midline glia are likely novel domains, although we cannot exclude the possibility that they were secondarily lost in *C. capitata* ([fig. 3*A--C* and *I*](#msx237-F3){ref-type="fig"})*.* Thus, our study case contains all the major evolutionary outcomes predicted for paralog expression divergence.

![Tissue-specific expression of the unduplicated ortholog. (*A--E*) mRNA localization of the unduplicated ortholog *a-36/38* in the *C. capitata* embryo. (*A*) There is no detectable expression in the heart (white arrow). The expression is detected in the axonal glia (*B*, red arrow) and the CNS surface glia (*B*, white arrow), the Bolwig\'s organ (*D*, white arrow), and the hindgut boundary cells (*E*, red arrow). No signal is detected in the midline glia (*B*) or the hemocytes (*C*). (*F--H*) *a-36/38* transcript localization in the tissues of the third instar larval tissues. (*F*) In the CNS, the expression was detected in a subset of neurons. In the eye disc, both the glia (*G*) and the photoreceptor neurons (*H*) showed expression. (*I*) Diagram summarizing the tissue-specific expression of *a-36/38*, *CG9336*, and *CG9338*. Lighter color denotes weak expression. The mRNA expression in the larval axonal glia of *C. capitata* could not be visualized by our in situ hybridization protocol. CAPA cells and garland cells could not be identified in *C. capitata*. L, larval; E, embryonic. See the main text for details.](msx237f3){#msx237-F3}

Interspecific Comparisons Reveal Paths to Sub- and Neo-Functionalization
------------------------------------------------------------------------

The observed expression divergence of *D. melanogaster CG9336* and *CG9338* may have evolved soon after the duplication event and remained fixed throughout the evolution of *Drosophila* genus. Alternatively, the divergence could have taken place at different time points in a lineage-specific manner, yielding diverse but related expression patterns in different lineages. To gain further insights into the trajectories of expression divergence followed by the two paralogs after the duplication event, we characterized the embryonic and larval expression patterns of both genes in *D. ananassae*, *D. pseudoobscura*, and *D. virilis* by in situ hybridization ([fig. 4](#msx237-F4){ref-type="fig"} and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The results are summarized in [figure 4*A*](#msx237-F4){ref-type="fig"}.

![Comparative analysis of the embryonic expression patterns of *CG9336* and *CG9338* orthologs. (*A*) Summary of tissue-specific expression of *CG9336* (blue) and *CG9338* (red) in four *Drosophila* species. Lighter colors denote weak expression and empty squares represent lack of expression. L, larval; E, embryonic. (*B--D\'*) In situ hybridization showing mRNA expression in the heart. In *D. ananassae* (*B, B\'*), *CG9336* is expressed most prominently in the cardiac cells in the anterior portion of the heart (*B*, arrow), with weaker expression in more posterior regions, whereas *CG9338* is not detected (*B\'*). In *D. pseudoobscura* (*C, C\'*), *CG9336 mRNA* is detected in few pericardial cells in the anterior heart (*C*, arrow), whereas *CG9338* mRNA is absent (*C\'*). In *D. virilis*, both paralogs are detected in the pericardial cells in the posterior heart (*D, D\'*, arrows), with *CG9338* being expressed more prominently (*D\'*). (*E, E\', G, G\', I, I\'*) Expression of the paralogs in the glia. In *D. ananassae* (*E, E\'*), both paralogs are expressed in the axonal glia of the PNS (red arrows) and the midline glia of the VNC (arrowheads). In the CNS surface glia, only *CG9338* is expressed (*E\'*, white arrow). In *D. pseudoobscura* (*G, G\'*), both paralogs are detected in the axonal glia (red arrows), in the midline glia (arrowheads) and, weakly, in the surface glia (white arrows). In *D. virilis* (*I, I\'*), both paralogs are expressed in the axonal glia of the PNS (red arrows), whereas only *CG9336* is detected the CNS surface glia (*I*, white arrow). Neither paralogs are expressed in the midline glia (black arrows). (*F, F\', H, H\', J, J\'*) Expression of the paralogs in the hemocytes, as shown in the embryonic head. The only paralog detected in these cells is *D. ananassae CG9338* (*F\'*, arrowhead). Both paralogs are expressed in the Bolwig\'s organ in all species (*K, K\', M, M\', O, O\'*). In the boundary cells of the hindgut, *CG9336* is expressed in all species (*L, N, P*; red arrows), whereas *CG9338* is absent in all species (*L\', N\', P\'*).](msx237f4){#msx237-F4}

Both paralogs are expressed in the Bolwig's organ ([fig. 4*K, K\', M, M\', O*, and *O\'*](#msx237-F4){ref-type="fig"}) and the embryonic axonal glia ([fig. 4*E, E\', G, G\', I*, and *I*](#msx237-F4){ref-type="fig"}\') in all the species examined. Another fully conserved feature concerns the hindgut boundary cells, which exclusively express *CG9336* in all four species ([figs. 2*E* and](#msx237-F2){ref-type="fig"}[4*L, 4N*, and *4P*](#msx237-F4){ref-type="fig"}), suggesting that this domain was asymmetrically inherited from the unduplicated ortholog ([fig. 3*E*](#msx237-F3){ref-type="fig"}) before the drosophilid radiation. In contrast, other complementary patterns appear to have arisen by inactivation of one of the paralogs in specific lineages. For example, although both genes are expressed in the eye disc glia of *D. melanogaster* and *D. virilis* ([fig. 2*M* and *S*](#msx237-F2){ref-type="fig"} and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}*M* and *P*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) only *CG9336* or *CG9338* are detected in *D. ananassae* or *D. pseudoobscura* eye discs, respectively ([supplementary fig. S2](#sup1){ref-type="supplementary-material"}*A, D, G*, and *J*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Similarly, in the embryonic CNS surface glia of *D. melanogaster* and *D. virilis*, only *CG9336* is present ([figs. 2*A, 2B*, and](#msx237-F2){ref-type="fig"}[4*I*](#msx237-F4){ref-type="fig"}), whereas *CG9338* alone is expressed in this tissue in *D. ananassae* ([fig. 4*E\'*](#msx237-F4){ref-type="fig"}).

The neofunctionalization events identified above in *D. melanogaster* also appear to have occurred at different time points in the paralog divergence process ([fig. 4*A*](#msx237-F4){ref-type="fig"}). In the case of the midline glia, the expression of both paralogs is conserved in all the species in both embryonic and larval stages ([figs. 2*A*, 2*G*, 2*N*, 2*T*, 4*A*,](#msx237-F2){ref-type="fig"}[4*E*, 4*E\'*, 4*G*, 4*G\'*](#msx237-F4){ref-type="fig"}, and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}*B, E, H*, and *K*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) with the exception of *D. virilis*, where the expression is only present in the larva ([fig. 4*A*](#msx237-F4){ref-type="fig"} and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}*N* and *Q*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Thus, this tissue specificity could have been acquired close to the duplication event, at least in the larva. Similarly, the embryonic heart expresses one or both paralogs in all the species examined ([fig. 4*A--D\'*](#msx237-F4){ref-type="fig"}). However, the extent of this expression is very variable, ranging from strong *CG9336* levels in the whole organ, as seen in *D. melanogaster* ([fig. 2*F* and *L*](#msx237-F2){ref-type="fig"}) to only a subset of cells, as observed in *D. pseudoobscura* ([fig. 4*C*](#msx237-F4){ref-type="fig"}). Thus, this tissue-specific expression could have also originated soon after the duplication and subsequently undergone spatial modifications in different lineages.

In contrast, other novel expression domains appear to have originated within specific lineages. For instance, the expression of *CG9338* in the embryonic hemocytes is only seen in *D. melanogaster* and *D. ananassae* ([figs. 2*I* and](#msx237-F2){ref-type="fig"}[4*F\'*](#msx237-F4){ref-type="fig"}). Further examples include the *CG9336* expression in the garland cells of *D. melanogaster* ([fig. 2*Q*](#msx237-F2){ref-type="fig"}) and in the eye photoreceptors of *D. pseudoobscura* ([fig. 4*A*](#msx237-F4){ref-type="fig"} and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}*G'*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Finally, we detected expression of *CG9336* ([fig. 2*N*](#msx237-F2){ref-type="fig"}) in the CAPA neurons of *D. melanogaster* and of both paralogs in *D. virilis* ([fig. 4*A*](#msx237-F4){ref-type="fig"} and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}*N'* and *Q'*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

In summary, our interspecific comparisons reveal that the present-day expression patterns of the two paralogs have been shaped by a series of lineage-specific events involving both the asymmetric inheritance of ancestral patterns and the acquisition of novel transcriptional profiles.

Characterization of the *Cis*-Regulatory Landscape Controlling Paralog Expression in *D. melanogaster*
------------------------------------------------------------------------------------------------------

We next sought to dissect the *cis-*regulatory regions of the *CG9336-CG9338* locus to determine the genetic basis of their shared and divergent expression patterns. For this purpose, we built a series of *D. melanogaster* GAL4 reporter constructs containing all the intronic and flanking intergenic regions of the two paralogs, with the exception of the short 58 bp intron 1 of *CG9338* ([fig. 5](#msx237-F5){ref-type="fig"}). For some regions, we built additional constructs with smaller overlapping fragments to better define the position of particular CRMs ([fig. 5](#msx237-F5){ref-type="fig"}). Comparing the tissue-specific activity of these reporters with the endogenous expression patterns of the two paralogs, we have uncovered a set of CRMs capable of driving expression in most of the native domains ([figs. 5 and](#msx237-F5){ref-type="fig"}[7](#msx237-F7){ref-type="fig"}, and [supplementary fig. S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Our results reveal a complex *cis*-regulatory architecture in which an array of modular enhancers distributed throughout the locus controls the tissue-specific expression of the two paralogs ([fig. 5](#msx237-F5){ref-type="fig"}).

![Locations of CRMs controlling the *CG9336* and *CG9338* expression in *D. melanogaster*. The diagram on the top shows VISTA plots displaying sequence conservation between the *D. melanogaster CG9336--CG9338* genomic region and homologous regions in different drosophilid species. Highly conserved regions between two species are represented as red (noncoding DNA) or purple (coding DNA) peaks. The coding regions of the two *D. melanogaster* paralogs and the adjacent genes are indicated above the plots. The region deleted in the *Df(2 L)Dc* mutant is shown between brackets. The *D. melanogaster*-specific insertion containing the *CR9337* pseudogene (white bar) is shaded in grey. We did not find any relevant enhancer activity associated with this region. Below the alignments, the genomic fragments included in different GAL4: VP16 reporter constructs are represented by black bars. Construct names are indicated with bold face capital letters. The inferred locations of different tissue-specific CRMs, narrowed down to minimal regions by comparison of overlapping constructs, are indicated in colored boxes (blue, glia; purple, hemocyte; orange, other). Higut, hindgut boundary cells; BO, Bolwig's organ; CAPA, CAPA-peptide abdominal neurons; Neph, nephrocytes (garland cells); AP, anal plate ring cells; Hrt, embryonic heart; Hemo, embryonic hemocytes; ML, embryonic and larval midline glia; E-Axon and L-Axon, embryonic and larval axonal glia; E-CNS Su and L-CNS Su, embryonic and larval CNS surface glia; L-EyeW, eye wrapping glia; L-EyeC, eye carpet glia. The confocal images are stack projections of embryonic and larval tissues showing mCD8-GFP (embryos, b/w) or mCD8-mCherry (larvae, b/w or green) reporter expression, driven by the different GAL4: VP16 constructs. The A construct drives expression in the embryonic Bolwig's organs (red arrow), the larval hindgut boundary cells, CAPA neurons, and nephrocytes. The C construct elicits expression in the embryonic anal plate and the larval hindgut boundary cells. Strong expression in both the heart (red arrow) and in dorsal muscles (red asterisks) is observed for the Dc 3′OL construct. The E construct drives the larval hindgut boundary cell expression. Both Fc 5′Hemo, and G constructs drive expression in embryonic hemocytes, visible here in stage 15 embryos. The D, Dc, Dc 5′Peak, Dc 3′Peak and Fc 3′OL constructs are active in the axonal glia in both stage 17 embryos (red arrows) and in third instar larvae (visible in green, red arrows). They also drive expression in the embryonic (arrowhead) and larval CNS surface glia (red arrowheads). The D construct, in addition, is active in the midline glia at both stages (white arrowheads). In the larval eye disc, Dc, Dc 5′Peak, Dc 3′Peak and Fc 3′OL drive expression in the carpet cells (white arrowheads), but only Dc and Dc 5′Peak drive expression in the eye wrapping glia (broad GFP signals in the eye disc).](msx237f5){#msx237-F5}

Specifically, we identified CRMs active in paralog-specific domains. *CG9336* expression in the CAPA neurons and the garland cells could be driven by modules present in the 5′ intergenic region of *CG9336* (Dmel A construct; [fig. 5](#msx237-F5){ref-type="fig"}), whereas the expression in the hindgut could be regulated by three CRMs (Dmel A, C, and E constructs, [fig. 5](#msx237-F5){ref-type="fig"}). Similarly, two modules present in intron 2 of *CG9338* and the 3′ intergenic region of *CG9338* (Dmel Fc 5′ Hemo and Dmel G constructs, [fig. 5](#msx237-F5){ref-type="fig"}) likely drive the expression of this gene in the hemocytes.

We also identified CRMs for domains shared by the two paralogs, such as the glial cells. We found two separate regions displaying enhancer activity in this tissue. One is located in the intergenic region and drives expression in all glial cell types that express the two paralogs (Dmel D construct, [fig. 5](#msx237-F5){ref-type="fig"}). Through enhancer bashing, we have delimited the glial enhancer activity to a 908-bp region immediately downstream of the *CG9336* coding region (Dmel Da construct). Further bashing of this construct indicates that this region contains at least three parts, driving both common and distinct expressions. Whereas the 5′ end harbors the midline glia activity, the central region (Dmel Dc5′ Peak construct) and the 3′ end (Dmel Dc3′ Peak construct) can independently drive expression in the rest of the glial domains ([fig. 5](#msx237-F5){ref-type="fig"} and [supplementary fig. S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). In fact, the only difference in the activities of the latter two is in the wrapping glia in the eye disc, where only the Dmel Dc 5′ Peak fragment is active ([fig. 5](#msx237-F5){ref-type="fig"} and [supplementary fig. S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The other glial CRM identified resides in the second intron of *CG9338* and drives expression in all glial domains, with the exception of the midline glia (Dmel F construct, [fig. 5](#msx237-F5){ref-type="fig"} and [supplementary fig. S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). This configuration thus suggests that the intergenic midline glia CRM could be shared by both paralogs, but each duplicate could have a dedicated CRM driving transcription in the other glial subtypes ([figs. 2 and](#msx237-F2){ref-type="fig"}[3*I*](#msx237-F3){ref-type="fig"}).

Other CRMs potentially shared by the two paralogs are the embryonic heart CRM, which overlaps extensively with the intergenic glial CRM (Dmel Dc3′ OL construct, [fig. 5](#msx237-F5){ref-type="fig"}), the anal plate CRM located in the *CG9336* Intron 2 (Dmel C construct, [fig. 5](#msx237-F5){ref-type="fig"}), and the Bolwig's organ CRM located in the 5′ upstream region of *CG9336* (Dmel A construct, [fig. 5](#msx237-F5){ref-type="fig"}). As we did not find other CRMs active in these tissues, any of these modules could be responsible for the expression of both *CG9336* and *CG9338* in these domains. However, we cannot rule out that additional CRMs present in the coding regions or outside the regions examined regulate the two genes.

Endogenous Deletion of the Dc Region Reveals the Activity of Shared Modules
---------------------------------------------------------------------------

To determine if the paralog coexpression in the embryonic glia and the heart is due to sharing of the intergenic enhancers ([fig. 5](#msx237-F5){ref-type="fig"}), we used the CRISPR/Cas9 technology ([@msx237-B21]) to delete the genomic region corresponding to the Dmel Dc construct ([figs. 5 and](#msx237-F5){ref-type="fig"}[6](#msx237-F6){ref-type="fig"}). We note that this deficiency, *Df(2 L)Dc*, which is fully viable, deletes a genomic region particularly well conserved among *Drosophila* species ([fig. 5](#msx237-F5){ref-type="fig"}). In *Df(2 L)Dc* homozygous embryos, the expression of both paralogs disappears in the heart and in all the glial tissues, including the midline ([fig. 6*C, C', D, G, G'*, and *H*](#msx237-F6){ref-type="fig"}). Thus, the intergenic CRMs appear to be shared and are essential for the embryonic glial and heart expression of both paralogs ([fig. 6*W*](#msx237-F6){ref-type="fig"}). This result also suggests that although the *CG9338* intron2 glial CRM is active in the embryo in the transgenic assay, it is not capable of driving the embryonic glial expression in its endogenous genomic context. Finally, our observations also indicate that the Dc region is necessary but not sufficient for the embryonic midline glia expression, as this fragment on its own does not display activity in this tissue ([fig. 5](#msx237-F5){ref-type="fig"} and [supplementary fig. S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

![Functional analysis of the Dc region in *D. melanogaster*. (*A--H'*) Expression of *CG9336* and *CG9338* in wild-type and *Df(2 L)Dc* embryos (stages 16 and 17) revealed by in situ hybridization (*A, A', C, C', E, E', G* and *G'*), anti-GFP staining in embryos expressing CG9336-YFP (*B, B', D, D'*) or CG9338-YFP (*F, F', H, H'*). (*A--H*) Ventral views showing expression of the two paralogs in the axonal glia (red arrows) and the midline glia (white arrowheads) of the CNS. In the mutants (*C, D, G, H*), the signal is absent in these two tissues. (*A', C', E', G'*) Dorsal views showing paralog expression in the heart (red arrows) and in a series of anterior epidermal stripes (white arrowheads). Heart expression is lost in the mutants (*C\', G\'*), but both paralogs are up-regulated in the epidermal stripes. (*B', D', F', H'*) Confocal stack projections of the anal plate region showing up-regulation of both paralogs in *Df(2 L)Dc* mutants. (*I--V*) Confocal stack projections of third instar larvae carrying the YFP-tagged proteins visualized with anti-GFP (b/w and green). Magenta shows Repo staining. In the larval CNS surface glia (*I* and *L*, red arrows) and the eye wrapping glia (*K* and *N*), the CG9336-YFP expression is lost in the mutant. The midline glia expression (white arrowheads) is reduced in the mutant larva (compare *J* and *M*). CG9338-YFP expression is not affected in the CNS glial cells (*O* and *S*), eye disc glia (*Q* and *U*), or axonal glia (*R* and *V*), but is lost in the midline glia (white arrowheads, compare *P* and *T*). (*W*) Schematic summarizing the inferred activity of different CRMs (colored rectangles) on the expression of the two paralogs in the embryonic and larval stages. The *Df(2 L)Dc* deletion is indicated by brackets. Directional activities of different CRMs on the two paralogs\' promoters are illustrated with arrows (plain lines, high activity levels; dotted lines, low levels). In the embryo, single CRMs for the anal plate (orange), the midline glia (pale blue), and the heart (red) drive *CG9336* and, at lower levels, *CG9338* expression in these tissues. A single shared intergenic CRM within the *Df(2 L)Dc* deletion is responsible for glial expression of both paralogs (dark blue). In the larvae, the shared midline glia CRM (light blue) also drives expression of both paralogs, but its deletion does not completely abolish the expression. The intergenic glial CRMs are responsible for *CG9336* activation in the CNS surface glia and the eye disc wrapping glia. *CG9338* glial expression is under the control of the second glial CRM located in its intron.](msx237f6){#msx237-F6}

In the *Df(2 L)Dc* larvae, *CG9336* expression is also abolished in the eye wrapping glia and the CNS surface glia but is only reduced in the midline glia ([fig. 6*I--N*](#msx237-F6){ref-type="fig"}). In contrast, the *CG9338* glial expression remains unaffected except in the midline, where it becomes undetectable ([fig. 6*O--V*](#msx237-F6){ref-type="fig"}). Thus, the Dc region is strictly required for *CG9336* midline expression in the embryo but not in the larva. We also observe that the *Df(2 L)Dc* deletion alters paralog expression in tissues a priori dependent on the activity of other CRMs. In particular, both paralogs are clearly up-regulated in a series of dorsal epidermal stripes and in the anal plate of mutant embryos ([fig. 6*A'--D'* and *E'--H'*](#msx237-F6){ref-type="fig"}). In contrast, in the larval stage, we did not observe paralog up-regulation or ectopic expression in the tissues examined ([supplementary fig. S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

In summary, our results reveal the complex nature of the regulatory logic operating in this locus and suggest the contribution of stage-specific enhancer--promoter and enhancer--enhancer interactions to the regulation of the two paralogs.

Interspecific Comparison of *Cis*-Regulatory Architectures
----------------------------------------------------------

To compare the *cis*-regulatory landscapes of the four drosophilids, we built for the other three species a series of GAL4 constructs containing the regions homologous to the *D. melanogaster* reporter constructs. We then assessed their activities in *D. melanogaster* transgenic hosts ([fig. 7](#msx237-F7){ref-type="fig"} and [supplementary figs. S4--S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Our data indicate that several aspects of the *cis*-regulatory architecture observed in *D. melanogaster* are preserved in the other species. To begin with, the positions of the two glial CRMs always coincide ([fig. 7](#msx237-F7){ref-type="fig"}). In addition, the location of the enhancers active in the Bolwig's organ (*CG9336* 5' region), the anal plate ring (*CG9336* Intron 2), and the heart (intergenic region) is conserved, as it is also the case for most of the multiple modules driving expression in the hindgut boundary cells (*CG9336* 5′, *CG9336* intron 2, and intergenic region, [fig. 7](#msx237-F7){ref-type="fig"}).

![Locations of tissue-specific CRMs in four *Drosophila* species. (Left) The top scheme shows the noncoding regions in the locus corresponding to the constructs A, C, DE (or D and E in *D. melanogaster*), F, and G, whose enhancer activities were tested. Green circles represent the tissue-specific CRMs found in each region. "E" and "L" before the tissue names indicate the embryonic and the larval stages, respectively. The lighter green circles indicate weak activities. (Right) Confocal images are stack projections showing the activities of the larval midline glia and the embryonic hemocyte CRMs from different species. For both tissues, the number and the location of CRMs vary among different species. A full description of the activities of all constructs tested is available in [supplementary figure S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online.](msx237f7){#msx237-F7}

Despite the conserved location of the two glial CRMs in the different species, fine-scale analysis reveals varying activities in the different glial subtypes ([fig. 7](#msx237-F7){ref-type="fig"} and [supplementary figs. S4--S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Importantly, this variation correlates with the endogenous expression of the paralogs in each species ([fig. 4*A*](#msx237-F4){ref-type="fig"}). For instance, both CRMs are active in the eye disc glia of *D. melanogaster* and *D. virilis*, where both paralogs are expressed ([fig. 4*A*](#msx237-F4){ref-type="fig"}). In comparison, *CG9338* is not detected in this tissue in *D. ananassae* ([fig. 4*A*](#msx237-F4){ref-type="fig"}), reflecting the lack of activity of its *CG9338* intron 2 CRM ([fig. 7](#msx237-F7){ref-type="fig"}; Dana F, Fb and Fc, [supplementary fig. S4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Similarly, the intergenic module of *D. pseudoobscura* is not active in the eye wrapping glia (although it is active in the thin carpet glial cells, which are not reliably stained with in situ hybridization; [fig. 7](#msx237-F7){ref-type="fig"}; Dpse D, [supplementary fig. S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), providing a potential explanation for the lack of *CG9336* expression observed in the eye glia of this species ([fig. 4](#msx237-F4){ref-type="fig"} and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}*G*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Based on these observations, we reasoned that in all species a dedicated CRM drives the transcription of each paralog in the eye disc glia. However, in other tissues, the regulatory logic controlling paralog expression seems to vary among species. As an example, our analysis of the *Df(2 L)Dc* mutants shows that the intergenic enhancer is the sole element controlling *CG9336* expression in the CNS surface glia of *D. melanogaster*. However, in *D. ananassae*, this CRM is not active in the embryonic surface glia ([fig. 7](#msx237-F7){ref-type="fig"}; Dana DE construct, [supplementary fig. S4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) and, accordingly, *CG9336* is not expressed ([fig. 4*A* and *E*](#msx237-F4){ref-type="fig"}). In contrast, the *CG9338* intron 2 CRM is active in this tissue ([fig. 7](#msx237-F7){ref-type="fig"}; Dana F, Fb and Fc, [supplementary fig. S4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) and *CG9338* is expressed ([fig. 4*E\'*](#msx237-F4){ref-type="fig"}). Thus, whereas a single CRM drives the embryonic glial expression of both paralogs in *D. melanogaster*, both CRMs appear to contribute to their expression in *D. ananassae*.

Overall, our results are consistent with the idea that most of the interspecific variations observed in the endogenous expression patterns are due to *cis*-regulatory divergence rather than *trans-*regulatory changes. This is further illustrated by the presence of CRMs active in the novel lineage-specific domains, including the hemocyte expression in *D. melanogaster* and *D. ananassae* ([fig. 7](#msx237-F7){ref-type="fig"}; in the constructs Dmel F and Dmel G, [fig. 5](#msx237-F5){ref-type="fig"}, and in Dana F, [supplementary fig. S4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), the *D. melanogaster CG9336* expression in the garland cells ([fig. 7](#msx237-F7){ref-type="fig"}; in Dmel A, [fig. 5](#msx237-F5){ref-type="fig"}), and the *D. pseudoobscura CG9336* expression in the eye photoreceptors ([fig. 7](#msx237-F7){ref-type="fig"}; in Dpse C, [supplementary fig. S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Taken together our data indicate that most of the lineage-specific sub- and neo-functionalization events under study result from changes in the activities of conserved CRMs or from the emergence of new modules.

Conserved Expression: Compensatory and Redundant Enhancers
----------------------------------------------------------

Although expression in several conserved domains appears to be driven by homologous CRMs, our interspecific comparisons reveal cases in which expression could be regulated by CRMs that exist in variable numbers and occupy different locations. For instance, whereas *D. melanogaster* and *D. ananassae* have a single midline glia CRM in the intergenic region, this activity resides in the second intron of *CG9336* in *D. pseudoobscura* and *D. virilis* ([fig. 7](#msx237-F7){ref-type="fig"}; constructs Dpse C and Dvir C, [supplementary figs. S5 and S6](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Moreover, *D. pseudoobscura* has an additional midline CRM in the *CG9338* intron 2 ([fig. 7](#msx237-F7){ref-type="fig"}; Dpse F construct, [supplementary fig. S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Thus, expression in this tissue depends on CRMs that have changed position during drosophilid evolution and appear to function as compensatory enhancers (also referred to as nomadic enhancers) ([@msx237-B30]; [@msx237-B1]).

Another such example is provided by the CRMs driving expression in the hindgut boundary cells. All four species have multiple CRMs active in this tissue but not always in homologous regions ([fig. 7](#msx237-F7){ref-type="fig"}). We also found that *D. pseudoobscura*, in comparison to the other species, has additional CRMs for the Bolwig's organ ([fig. 7](#msx237-F7){ref-type="fig"}; *CG9336* Intron 2, Dpse C, [supplementary fig. S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) and the heart (*CG9338* Intron 2, Dpse F, [supplementary fig. S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Similarly, *D. virilis* has two CAPA neuron CRMs (Dvir A and Dvir F, [supplementary fig. S6](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). However, given that in this species both genes are expressed in these cells ([fig. 4*A*](#msx237-F4){ref-type="fig"} and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}*N\'* and *Q\'*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), each module could be dedicated to a specific paralog, as it could also be the case for the two *D. pseudoobscura* midline CRMs ([fig. 7](#msx237-F7){ref-type="fig"}; Dpse C and F, [supplementary fig. S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Finally, *D. melanogaster* has two CRMs driving expression in the embryonic hemocytes ([fig. 7](#msx237-F7){ref-type="fig"}; Dmel Fc 5′ Hemo and Dmel G, [fig. 5](#msx237-F5){ref-type="fig"}). Thus, these modules could potentially control *CG9338* expression in these cells in a redundant manner.

In summary, our locus-wide inventory of enhancer activities uncovers that conserved expression features can also rely on a highly evolvable *cis*-regulatory architecture.

Discussion
==========

Lineage-Specific Changes Shaped Evolving Expression Patterns during Paralog Divergence
--------------------------------------------------------------------------------------

Few empirical studies have directly examined the contribution of *cis*-regulatory evolution to the functional divergence of gene paralogs ([@msx237-B25]; [@msx237-B29]; [@msx237-B35]; [@msx237-B38]). In this work, we have characterized the expression patterns of a pair of tandem duplicates and its underlying *cis*-regulatory basis in four drosophilid species. We have surveyed in this way a diversification process of 40 My, the estimated age of the last common ancestor of the species analyzed ([@msx237-B56]; [@msx237-B45]). Based on the phylogeny, we could infer that many of the present-day expression divergence between *CG9336* and *CG9338* have been shaped by lineage-specific sub- and neo-functionalization events after fixation of the two paralogs ([fig. 4](#msx237-F4){ref-type="fig"}). This and two additional observations argue against the initial preservation of the two paralogs through the rapid acquisition of complementary patterns, which evolved immediately after the duplication event ([@msx237-B46]; [@msx237-B14]). First, paralog coexpression is still prevalent in many tissues ([figs. 3*I* and](#msx237-F3){ref-type="fig"}[4*A*](#msx237-F4){ref-type="fig"}) and, second, at least in the two developmental stages examined, we could not detect ancient domains unique to *CG9338*, which would have made its initial retention necessary. Thus, alternative processes such as sharing of the ancestral gene dose between the two paralogs could have been determinant for their initial maintenance in the genome, which was then followed by subfunctionalization in certain lineages ([@msx237-B37]; [@msx237-B64]).

The dosage-sharing mechanism, in fact, has been reported as prevalent among tandem duplicates, both in mammals and in different populations of *D. yakuba* ([@msx237-B37]; [@msx237-B54]). In tandem configurations, presumably, the shared *cis-*regulatory environment allows the maintenance of the overlapping expression domains for prolonged periods, whereas other mechanisms could alter the total level of transcription from the duplicated coding units. As detailed below, our study provides a clear example where shared enhancers contribute to the coregulation of the two paralogs in an ancestral expression domain. However, our results also illustrate ways in which *cis*-regulatory evolution can decouple paralog regulation. Our data thus provide empirical support to the notion that the dynamic properties of CRMs facilitate the emergence of divergent paralog expressions and functional specialization in specific cellular contexts.

*Cis*-Regulatory Evolution and the Emergence of Novel Tissue-Specific Enhancers
-------------------------------------------------------------------------------

Our results show that most of the evolutionary changes generating expression pattern divergence of *CG9336* and *CG9338* have a *cis*-regulatory basis. Our assay of tissue-specific enhancer activities relied on a heterologous expression system, as all the activities of CRMs were monitored in the *D. melanogaster* host. The fidelity of this approach thus depends on a high degree of conservation in the *trans*-regulatory networks operating among the species examined, a feature of our experimental system that has been extensively tested by many previous studies ([@msx237-B41]; [@msx237-B30]; [@msx237-B16]; [@msx237-B53]; [@msx237-B2]; [@msx237-B1]; [@msx237-B67]). Although we cannot completely rule out that some of the expression differences observed are due to evolutionary changes in upstream regulatory networks, most of the reporters analyzed respond to the *trans*-regulatory landscape of *D. melanogaster* and collectively recapitulate the tissue-specific patterns observed in their respective endogenous species. For instance, this is clearly the case for the five neofunctionalization events identified in our data set, where for each novel expression domain we have detected the concomitant emergence of tissue-specific CRMs ([fig. 7](#msx237-F7){ref-type="fig"}; heart, midline glia, hemocytes, eye photoreceptors, and garland cells). As some of these CRMs are only found in single lineages, it indicates that the CRM with novel tissue-specific activities appeared in relatively short evolutionary timescale contributing to the rapid expression divergence of the paralogs.

Conserved Glial CRMs and Paralog Expression Divergence
------------------------------------------------------

The most conserved *cis-*regulatory feature of the *CG9336--CG9338* locus is the presence of two glial CRMs, which collectively control the expression of the two paralogs in these tissues ([fig. 7](#msx237-F7){ref-type="fig"}). These modules are located in homologous regions in all the species examined, and the intergenic glial CRM is indeed the only regulatory element in the locus displaying significant sequence conservation ([fig. 5](#msx237-F5){ref-type="fig"}). Our data show that despite many similarities, the activities of these two CRMs are not equivalent ([fig. 7](#msx237-F7){ref-type="fig"}) resulting in the divergent expression of the two paralogs in this tissue.

First, our analysis of the reporter constructs showed that the two CRMs display different enhancer activities within the glial subtypes indicating that they integrate common developmental cues, hence their redundancy in some glial subtypes, but also distinct inputs, allowing, for instance, differential expression in the eye carpet and wrapping glia ([fig. 7](#msx237-F7){ref-type="fig"}). Second, by deleting the intergenic glial CRM in *D. melanogaster*, we demonstrated that the two glial CRMs have distinct temporal requirement as well as different capacities to interact with the promoters of each paralog ([fig. 6](#msx237-F6){ref-type="fig"}). Together, these differences contribute to the partially overlapping glial expression of the two paralogs ([fig. 7](#msx237-F7){ref-type="fig"}).

Evolutionary changes in the capacities of the two CRMs also appear to underlie the interspecific variation. We have observed in the different species several examples of subfunctionalization in glial subtypes that correlate with changes in the activity of the two glial CRMs ([figs. 4 and](#msx237-F4){ref-type="fig"}[7](#msx237-F7){ref-type="fig"}). However, whether the promoter preferences of these CRMs have also changed during evolution is difficult to establish in absence of functional data describing their endogenous activity. It is nevertheless tempting to speculate that in coregulated loci, expression divergence may not exclusively depend on the inactivation of specific enhancers but also on the dynamic modulation of enhancer--promoter interactions, which, as we have shown, can contribute to gene regulation integrating both temporal and spatial developmental cues.

Redundant Enhancers and the Evolution of *Cis-*Regulatory Architecture
----------------------------------------------------------------------

Previous studies have demonstrated the pervasive presence of redundant CRMs (enhancers with overlapping tissue activities) in the genome of *D. melanogaster* ([@msx237-B15]; [@msx237-B12]; [@msx237-B55]; [@msx237-B9]; [@msx237-B67]). Our locus is not an exception to this trend, and the glial CRMs are not the only redundant modules we identified ([fig. 7](#msx237-F7){ref-type="fig"}). Interestingly, we found that the number and location of these redundant enhancers vary among species, suggesting that they can undergo lineage-specific births and losses ([fig. 7](#msx237-F7){ref-type="fig"}). As proposed by [@msx237-B30], such a dynamic pattern of enhancer evolution is likely to underlie the existence of compensatory enhancers.

Specifically, we found in different species two and even three different CRMs driving expression in the hindgut boundary cells. Although it could be argued that some of these modules may not be functional in their endogenous context, these CRMs appear to interact specifically with the *CG9336* promoter, as only this paralog is expressed in this tissue. This suggests that selective pressures acting on the promoter preference of these CRMs could prevent paralog coexpression in this tissue. This example demonstrates that variations in both CRM number and position do not necessarily translate into interspecific differences in the expression of the two paralogs. However, this underlying variation could potentially lead to operational changes in the *cis*-regulatory logic. For example, both *CG9336* and *CG9338* are expressed in the midline glia in all species ([fig. 4](#msx237-F4){ref-type="fig"}), and a single midline glial CRM drives their expression in *D. melanogaster*, *D. ananassae*, and *D. virilis* ([fig. 7](#msx237-F7){ref-type="fig"}). However, in *D. pseudoobscura*, there are two midline CRMs ([fig. 7](#msx237-F7){ref-type="fig"}). This raises the possibility that in this species, a paralog-specific enhancer could control the midline expression of each gene. If this was the case, the emergence of a redundant module could have promoted the transition from the state of coregulation to that of independent regulation. Thus, the recurrent appearance of redundant enhancers could present opportunities to decouple paralog regulation in specific tissues, a process that may play a recurrent role during paralog divergence.

The Role of Endogenous Genomic Context in Paralog-Specific Regulation
---------------------------------------------------------------------

Our observations reveal that the developmental regulation of the two paralogs requires the contribution of dynamic enhancer--promoter interactions. Two additional observations further highlight the role played by the endogenous genomic context in the transcriptional regulation of this locus. First, we have shown in the *Df(2 L)Dc* mutants that the deletion of a CRM can perturb the activity of other CRMs, suggesting that enhancer--enhancer interactions may also contribute to paralog regulation ([fig. 6](#msx237-F6){ref-type="fig"}). Second, we observed that the activities of some of our reporters do not recapitulate the stage- and tissue-specific variations observed in the expression of the endogenous transcripts ([figs. 2,](#msx237-F2){ref-type="fig"}[4,](#msx237-F4){ref-type="fig"}[7](#msx237-F7){ref-type="fig"}, and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). For instance, *CG9336* expression in the axonal glia is restricted to embryonic stages in all the species except in *D. virilis*. However, all the reporter constructs containing the axonal glial CRMs are active in both embryonic and larval stages ([figs. 4 and](#msx237-F4){ref-type="fig"}[7](#msx237-F7){ref-type="fig"}).

Altogether, these findings are consistent with the notion that the coordinated expression of tandem duplicates depends on the complex interaction of CRMs with other encoded elements, including other enhancers, tethering elements, repressors, insulators, and local chromatin regulators, which contribute to restrict CRM activity to specific paralogs, developmental stages, or cell types ([@msx237-B8]; [@msx237-B10]; [@msx237-B29]; [@msx237-B65]; [@msx237-B36]; [@msx237-B39]; [@msx237-B43]). These interactions can thus become potential targets of evolutionary changes during paralog divergence, just as the individual activities of each CRM.

This work is one of the first empirical analyses describing the expression evolution of a duplicated gene pair in closely related species. The rapidly evolving nature of the paralogs has permitted an unprecedented level of detail in the dissection of the mechanisms shaping their expression evolution. This gene pair and other loci with equivalent properties can thus constitute promising study systems, which can help us gain deeper understanding of gene regulatory evolution. With the advent of genome editing technology, which can be applied to non-model drosophilids ([@msx237-B13]; [@msx237-B31]; [@msx237-B60]), the inquiry into *cis*-regulatory evolution can progress beyond the study of individual enhancers and to the functions of other layers of *cis*-regulation.

Materials and Methods
=====================

Sequences and Phylogeny
-----------------------

The genomic sequences covering the *CG9336--CG9338* region were obtained from the *D. melanogaster* R6.13, *D. yakuba* R1.05, *D. ananassae* R1.05, *D. pseudoobscura* R3.04, and *D. virilis* R1.06 genome releases and were pairwise aligned using the mVISTA tool ([@msx237-B17]). Protein coding and amino acid sequences were aligned using the Clustal Omega software with the default settings (<http://www.ebi.ac.uk/Tools/msa/clustalo/>; last accessed September 13, 2017). The GenBank sequence accession numbers are: *Dmel36*, NM_136225; *Dyak36*, XM_002090241; *Dana36*, XM_001965237; *Dpse36*, DR121923; *Dvir36*, XM_002052027; *Dgri36*, XM_001988362; *Dmel38*, NM_136227; *Dyak38*, XM_002090240; *Dana38*, XM_001965236; *Dpse38*, XM_002132762; *Dvir38*, XM_002052026; *Dgri38*, XM_001988361; *Ccap3638*, XM_004524746; and *Bcuc3638*, XM_011189182. The sequences of the coding regions were used to compute the gene tree ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) with the Maximum Likelihood method in MEGA6 package ([@msx237-B61]), using the Tamura--Nei model.

Animal Husbandry and Fly Stocks
-------------------------------

Wild-type strains of *D. melanogaster*, *D. ananassae*, *D. pseudoobscura*, and *D. virilis* came from the Drosophila Species Stock Center (San Diego, USA). The YFP-reporter lines used were the YFP protein trap lines, *CG9336^CPTI001654^* (DGRC \#115180) and *CG9338^CPTI100000^* (DGRC \#115071). In these lines, the YFP is incorporated into the endogenous products, which remain under the control of their native *cis-*regulatory regions ([@msx237-B40]). Other *D. melanogaster* strains used include the reporters *UASmCD8-GFP* (Bloomington\#5137) and *UASmCD8-mCherry* (B\#27392), and the GAL4 drivers *w; breathless-GAL4^S2^, UASActin5C-GFP* (B\#8807), and *P(GawB)Mz97-GAL4* ([@msx237-B27]). We also used the integration platform *y sc v P(nos-phiC31)*; *P(CaryP)attP2* (B\#25710); and the *y w vasa-Cas9* stock (B\#51323). Balancers combinations used were *w; TM3/TM6B*, *w*; *amos^Tft^/CyO wg-lacZ*, *w; wg^Sp1^/CyO tub-PBac T* (B\#8285), *w; wg^Gla1^/CyO twist-GAL4 UAS-GFP* (B\#6662), and *w; sna^Sco^/CyO, PsChFP2* (B\#35523). The drosophilid cultures were raised at 25 °C in standard cornmeal medium. The *C. capitata* culture (kindly provided by Dr A. Jessup, IAEA Seibersdorf, Austria) was maintained at 25 °C on a diet of sugar and hydrolyzed yeast protein for the adults and on a *Drosophila* food medium for the larvae.

mCherry-Tagged Proteins and Live Imaging
----------------------------------------

For the generation of full length CG9336 and CG9338 tagged with mCherry, the mCherry coding sequence, flanked on each side by a single L residue, was introduced in frame between the predicted signal peptide (conserved residue Y22) and their respective three finger domains (see [fig. 1*B*](#msx237-F1){ref-type="fig"}). We used the RE67340 (CG9336) and GH07967 (CG9338) EST clones (DGRC) as cDNA templates. Constructs were then sequenced and subcloned into the pUAST vector for the generation of transgenic strains permitting ectopic expression of each protein under the control of the GAL4 system ([@msx237-B6]). For imaging, third instar larvae were dissected and immediately mounted in Schneider S2 medium (Gibco) between a slide and a coverslip separated by thin spacers. Tissues were imaged within 20 min, using a Zeiss 710 confocal microscope.

Reporter Constructs
-------------------

The intronic, intergenic, and flanking noncoding regions of *CG9336* and *CG9338* from the four drosophilid species in this study were PCR-amplified from genomic DNA, using the Phusion High-Fidelity DNA polymerase (NEB). Primer combinations used are described in the [Supplementary Material](#sup1){ref-type="supplementary-material"} online. PCR products were cloned into the Gateway pENTR1A Dual Selection Vector (Invitrogen) or Gateway pENTR/D-TOPO Vector (Invitrogen), then sequenced to verify the identity and orientation of the inserts (the 5′ intergenic regions were inserted in the 5′-3′ orientation relative to the promoter, whereas the rest was inserted in the 3′-5′ orientation). Using the Gateway LR Clonase II system (Invitrogen), the inserts were transferred to the pBPGAL4.2: VP16Uw vector ([@msx237-B50]), which contains a mini-white marker and an attB sequence for site-specific integration. Each construct was injected at a concentration of 0.5--1 µg/µl into *y sc v P(nos-phiC31); P(CaryP)attP2* embryos expressing the phiC31 site-specific integrase. Emerged adults were crossed to *y w* flies, and the progeny was screened for *w*^+^ insertions.

In Situ Hybridization
---------------------

To synthesize paralog-specific riboprobes for each species, 3′ or 5′ untranslated regions were cloned from embryonic cDNA libraries and used as templates. The sequences of the cloning primers and the probes are listed in the [Supplementary Material](#sup1){ref-type="supplementary-material"} online. Embryos were dechorionated and fixed according to [@msx237-B63]. In situ hybridization was carried out as in [@msx237-B47] based on [@msx237-B63] with the following modifications: *C. capitata* embryos were incubated for 3 min in 4 µg/ml proteinase K at 37 °C, and the hybridization buffer included heparin instead of glycogen. Hybridization was carried out at 60 °C. Embryos were mounted in 70% glycerol in phosphate-buffered saline (PBS) and observed under the Leica DM LB2 upright microscope.

Third instar wandering larvae were dissected in PBS, fixed for 30 min in 4% formaldehyde in PBT (PBS, 0.1% Tween-20) and dehydrated in 100% methanol. Samples were rehydrated in 1:1 methanol/5% formaldehyde in PBT (5 min), postfixed in 5% formaldehyde in PBT (30 min), and washed three times for 10 min in PBS-Triton (PBS, 0.1% Triton X-100). After incubation for 5 min in 50 µg/ml proteinase K at room temperature in PBS-Triton, tissues were postfixed for 30 min in 5% formaldehyde in PBS-Triton. Hybridization was carried out overnight at 55 °C. Tissues were mounted in 60% glycerol and imaged in a Nikon Eclipse 80i microscope equipped with a DXM1200C digital camera.

Analysis of Reporter Expression and Immunohistochemistry
--------------------------------------------------------

For the analysis of embryonic reporter activities, males from each line were crossed with *UASmCD8-GFP* virgin females. Embryos were fixed as indicated above and blocked in 5% normal goat serum in PBT for 30 min. Primary and secondary antibody incubations and washing steps were carried out in PBT. All samples were imaged on a Leica SP5 inverted confocal microscope. Reporter activities in the larva were analyzed in the third instar stage in the progeny of a cross between males of each reporter strain and *CG9336^CPTI001654^; UASmCD8-mCherry* or *CG9338 ^CPTI100000^; UASmCD8-mCherry* virgin females to assess the match with the endogenous expression. Larval tissues were fixed as described above for 20 min. Subsequent blocking, 4 °C overnight antibody incubations and washes were carried out in PBS-Triton with 0.1% BSA. All samples were mounted in VECTASHIELD (Vector Laboratories) and imaged on a Leica SP8 upright confocal microscope. The antibody concentrations used were 1:1000 rabbit anti-GFP (Molecular Probes), 1:50 mouse anti-Repo (8D12, DSHB), 1:1000 Alexa488 anti-rabbit, and 1:1000 Alexa546 anti-Mouse (Invitrogen). All images were processed using Fiji software ([@msx237-B58]) and Adobe Photoshop (Adobe Systems).

CRISPR/Cas9-Mediated Genome Engineering
---------------------------------------

The *Df(2 L)Dc* deletion lines were generated by first replacing the Dc region with a DsRed marker via homology directed repair, followed by the removal of the marker. The single-guide RNA (sgRNA) target sites were searched using the fly CRISPR Optimal Target Finder online tool ([@msx237-B21]). Oligonucleotides corresponding to these sites were cloned into the pCFD3-dU6: 3gRNA vector to make the sgRNA plasmids ([@msx237-B20]). For building the donor plasmid containing the DsRed marker, ∼1 kb regions flanking the Dc region (homology arms) were PCR-amplified from genomic DNA of the *y w vasa-Cas9* line with the Phusion High-Fidelity DNA polymerase (NEB), then cloned into the pHD-ScarlessDsRed vector (obtained from DGRC), using the In-Fusion HD cloning kit (Clontech). Sequences of the cloning primers for the homology arms and sgRNAs are available in the [Supplementary Material](#sup1){ref-type="supplementary-material"} online. A mix of two sgRNA plasmids and the donor plasmid (100 and 500 ng/µl, respectively) was injected into embryos of three different strains: *y w vasa-Cas9*, *y w vasa-Cas9; CG9336^CPTI0016^*^*54*^, and *y w vasa-Cas9; CG9338^CPTI100000^*.

Emerging males were crossed with *w*; *amos^Tft^/CyO wg-lacZ* flies and the F1 male progeny was screened for DsRed-positive individuals. Stocks carrying the insertions were established, using the *w; wg^Gla1^/CyO twist-GAL4 UAS-GFP*, and *w; sna^Sco^/CyO, PsChFP2* balancers. Removal of the DsRed cassette (which is flanked by PBac transposon ends) was accomplished using the *w; wg^Sp1^/CyO tub-PBac T* strain as a Piggy-Bac transposase source. Males carrying both the DsRed insertions and the transposase chromosome were crossed to *w*; *amos^Tft^/CyO wg-lacZ* virgin females, and their progeny was screened for the loss of DsRed signal. Deletions were verified by PCR analysis of genomic DNA using flanking primers.

Supplementary Material
======================

[Supplementary data](#sup1){ref-type="supplementary-material"} are available at *Molecular Biology and Evolution* online.
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